2019 Cannabis Business Award's Publication of the Year |
WEDNESDAY, MARCH 19, 2025 |
FMCPG HAS BEEN SERVING AND REPRESENTING THE CANNABIS PHYSICIAN COMMUNITY
SINCE 2020 |
THE "FLORIDA MEDICAL CANNABIS PHYSICIAN GROUP" (FMCPG) FOR ALL "MEDICAL MARIJUANA DOCTORS" AND "MMTC DIRECTORS ONLY "
DISCUSSION WILL INCLUDE:
LEGISLATIVE AGENDA FOR 2025
TRUMP APPOINTMENTS EFFECT ON THE CANNABIS INDUSTRY IN FLORIDA
REVIEW OF THE OMMU AND CHANGES TO THE DOCTOR'S PATIENT INPUT PORTAL ON THE OMMU WEBSITE.
DOCTORS WITHIN OUR GROUP WILL DISCUSS HOW THEY HAVE BEEN WORKING AROUND SOME OF THE CHANGES
REF'S ISSUES AND SOLUTIONS
USE THIS LINK TO JOIN MEETING TO PRE- REGISTRATION - THURSDAY, APRIL 3, 2025
CLICK HERE ON LINK BELOW
https://us02web.zoom.us/meeting/register/eAiv_F4ZSHujO7JmOZcVaw
Meeting ID: 878 4462 8121
Passcode: 354544 |
MEDICAL CANNABIS PHYSICIAN PROMOTION PACKAGE BY CANNABIS NEWS FLORIDA
ARTICLE: Physician will contribute an article of 350 words**. This article will appear in the Cannabis News Florida e-newsletter for one month (4 weeks).
E-MAIL BLAST: Cannabis News Florida will send out one e-mail blast promoting the Physician to the other physicians in three zip code areas or one city to be determined by the Physician. The Physician will supply the information for the email blast. The Article above can be used in the e-mail blast.
The cost of this program is ONLY $500.
**Cannabis News Florida will assign a writer for a telephone interview with the Physician and create the article to be published. Physician shall have the right to review and approve the article before publication for an additional cost of $100.
IF YOU ARE INTERESTED, PLEASE EMAIL ME AT CHARLES@CANNABISNEWSFLORIDA.COM OR CALL MY CELL AT 954-605-4785 |
NEWS FROM THE PAST WEEK
RELATING TO THE BUSINESS OF MMTC'S
IN FLORIDA Click on Company Logo to be Transferred to Web Site
|
Trulieve to Open Medical Cannabis Dispensary in North Miami Beach, Florida
New Miami-Dade County location will host grand opening celebration Friday, March 21st
TALLAHASSEE, Fla., March 18, 2025 — Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) (“Trulieve” or “the Company”), a leading and top-performing cannabis company in the U.S., today announced the opening of a new medical cannabis dispensary in North Miami Beach, Florida.
A grand opening celebration will be held Friday, March 21, beginning at 9 a.m., featuring music, specials, discounts, and opportunities to register for upcoming patient education sessions.
“We are proud to expand access to medical cannabis in Miami-Dade County,” said Trulieve’s Chief Executive Officer Kim Rivers. “We look forward to serving patients and caregivers at this new location with our affordable, high-quality products and elite customer experience.”
Trulieve North Miami Beach 167th Street, located at 175 Northwest 167th Street, will be open 9 a.m. – 8:30 p.m. Monday through Saturday and 11 a.m. – 8 p.m. on Sundays, offering walk-in and express pickup service.
The new dispensary will carry a wide variety of popular products including Trulieve’s portfolio of in-house brands such as Alchemy, Co2lors, Cultivar Collection, Modern Flower, Momenta, Muse, Roll One, Sweet Talk, and Trekkers. Customers will also have access to beloved partner brands such as Alien Labs, Bellamy Brothers, Binske, Black Tuna, Blue River, Connected Cannabis, DeLisioso, Khalifa Kush, Love’s Oven, Miami Mango, Seed Junky, and Sunshine Cannabis, all available exclusively at Trulieve in Florida.
READ MORE |
The Hand Trim Difference: Why it’s Worth It
There’s trimming, and then there’s trimming. Machine-trimmed flower? Quick and dirty. Hand-trimmed flower? A craft, an art, a labor of love. If you’ve ever cracked open a beautifully frosted bud and marveled at its perfection, chances are, a skilled hand-trimmer made it happen.
Why Hand Trimming Wins Every Time A good trim isn’t about hacking a bud down to size—it’s about *enhancing* what nature did best. The goal is simple: Keep the bud’s natural structure intact
Preserve the delicate trichomes and pistils Deliver a top-shelf product that actually looks and smokes like one Machine trimming? That’s where things get dicey. It’s fast, but it’s rough. Trichomes get knocked off, structure gets flattened, and suddenly, that fire flower looks like it went through a rock tumbler. Precision Over Speed
No two buds are the same, and hand trimming gives each one the custom treatment it deserves. It’s not about mindlessly chopping—it’s about sculpting. A good trim keeps the strain’s unique shape and density intact, instead of shaving everything down to a machine-made blob. Less Handling, More Integrity Trichomes are where the magic happens, and they’re delicate. Hand trimmers hold the bud by the stalk, trimming with care to preserve potency and flavor. Machines? They toss the flower around like it’s a load of laundry, knocking off precious trichomes in the process.
Let the Strain Shine Some strains are compact and dense, others are fluffier and more open. Hand trimming lets each one show off its natural beauty, instead of forcing every nug into the same cookie-cutter shape. It’s the difference between craft and mass production—and trust us, you *can* tell. The Verdict Hand trimming takes longer, but the payoff is huge. Better structure, better bag appeal, better potency. It’s the difference between good weed and *great* weed. If you care about quality, you already know—it’s worth the extra love. READ MORE |
The Cannabist Company Reports Fourth Quarter and Full Year 2024 Results
NEW YORK—Mar. 13, 2025– The Cannabist Company Holdings Inc. (Cboe CA: CBST) (OTCQX: CBSTF) (FSE: 3LP) (“The Cannabist Company” or the “Company”), one of the most experienced cultivators, manufacturers and retailers of cannabis products in the U.S., today reported its financial and operating results for the fourth quarter and full year ended December 31, 2024. All financial information presented in this release is in U.S. GAAP, unaudited, and in thousands of U.S. dollars, unless otherwise noted.
“As we continued our Company’s transformation throughout 2024, we implemented structural changes to the business and executed on key initiatives to optimize our retail and cultivation assets, divest non-strategic assets, root out supply chain inefficiencies, and capitalize on adult use adoption in Ohio. Employing a comprehensive approach to balance sheet management, on February 27, we announced an agreement to extend the maturities on our senior secured debt until December 2028, with options to extend through 2029. With currently 70% support from our noteholders, we are confident that this process will be completed. This transaction provides runway for us to focus on the continued optimization of our business, as we complete divestitures, continue to reduce operating and overhead costs, refine our inventory assortment, and improve the operational and financial performance of the company,” said David Hart, CEO of The Cannabist Company.
He continued, “Our mandate in 2025 is to continue to simplify our business, maintain liquidity, improve margins, and drive cash flow generation, putting us in a position to succeed. We have meaningful catalysts in 2025, including the transition to adult use in Delaware and the addition of retail locations in top markets such as Virginia and Ohio.”
Top 5 Markets by Revenue in Q4[3]: Colorado, Maryland, New Jersey, Ohio, Virginia
Top 5 Markets by Adjusted EBITDA in Q4[3]: Maryland, New Jersey, New York, Ohio, Virginia
READ MORE |
Green Thumb Opens Sixth Ohio Location, RISE Dispensary Whitehall
RISE Dispensaries will serve patients and adult-use customers of Central Ohio with the opening of RISE Dispensary Whitehall located at 4141 E Broad St., Whitehall, OH 43213.
RISE Dispensary Whitehall is the first RISE in the Columbus, Ohio area and sixth RISE in the state.
Continuing with RISE’s new store opening tradition, profits from RISE Dispensary Whitehall will be donated to Home for Families following the opening on March 21.
CHICAGO and VANCOUVER, British Columbia, March 14, 2025 — RISE Dispensaries, a rapidly growing cannabis retail chain owned by Green Thumb Industries Inc. (“Green Thumb” or the “Company”) (CSE: GTII) (OTCQX: GTBIF), today announced the opening of RISE Dispensary Whitehall, located at 4141 E Broad St., Whitehall, OH 43213, on March 14. The new Whitehall location, marking the Company’s entry into the Columbus area, is the sixth RISE Dispensary in Ohio and 103rd nationwide. This is the first RISE Dispensary to open in Ohio since adult-use sales launched in Ohio in August 2024.
Beginning March 14, RISE Dispensary Whitehall will bring patients and adult-use customers hand-picked, high-quality products and key service offerings, such as curbside pickup. RISE Dispensary Whitehall will be open on March 14 from 4:20 p.m. to 9:00 p.m. and from 8:00 a.m. to 9:00 p.m. every day thereafter, offering a broad selection of curated products from Green Thumb’s family of brands, including RYTHM, incredibles, Beboe, Good Green, &Shine and Doctor Solomon’s.
“It is an exciting day for Green Thumb in the Buckeye State as we open our sixth RISE Dispensary in Ohio and first location in the Columbus area,” said Green Thumb President Anthony Georgiadis. “We are eager to offer Central Ohio patients and customers our best-in-class retail experience and greater access to some of Ohio’s top-selling brands, including RYTHM and incredibles.”
Building on the RISE tradition of giving back to a local charity upon opening, RISE Dispensary Whitehall will donate a portion of profits to Home for Families, a Columbus-based organization committed to preventing and ending homelessness for Central Ohio families on March 21 Home for Families partners with families and youth to resolve their housing crises, strengthen financial stability, and bridge education gaps to prevent future homelessness.
READ MORE |
Cresco Labs’ Disciplined Strategy Drives Record Cash Flow in 2024 Financial Results
Record full year operating cashflow of $132 million, an increase of 126% from the prior year period
CHICAGO–MARCH 12. 2025 – Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF) (FSE: 6CQ) (“ Cresco Labs ” or the “ Company ”), the industry leader in branded cannabis products with a portfolio of America’s most popular brands and the operator of Sunnyside dispensaries, today released its financial and operating results for the fourth quarter and year ended December 31, 2024. All financial information presented in this release is reported in accordance with U.S. GAAP and in U.S. dollars, unless otherwise indicated, and is available on the Company’s investor website, here.
Fiscal Year 2024 Highlights
Revenue of $724 million. Record operating cash flow of $132 million and Free Cash Flow1 of $114 million.
Gross profit of $364 million. Adjusted gross profit1of $374 million; and an Adjusted gross margin1of 52% of revenue, a 270 bps improvement year-over-year.
SG&A of $221 million. Reduced Adjusted SG&A1by 12% year-over-year to $212 million, or 29% of revenue.
Net loss of $60 million which includes one-time, non-cash charges of $66 million, related to Company’s expected benefits from its updated 280E position, as initially described in the second quarter of 2024.
Adjusted EBITDA1of $200 million, up 15% year-over-year; and Adjusted EBITDA margin1of 28%, a nearly 510 bps improvement year-over-year.
Retained the No. 1 share position in Illinois, Pennsylvania and Massachusetts for the full year.2
Fourth Quarter 2024 Highlights
Fourth quarter revenue of $176 million. Fourth quarter operating cash flow of $29 million and Free Cash Flow1 of $27 million.
Gross profit of $84 million. Adjusted gross profit1of $87 million; and an Adjusted gross margin1of 50% of revenue.
SG&A of $56 million or 32% of revenue.
Net income of $0.4 million.
Fourth quarter Adjusted EBITDA1of $42 million and Adjusted EBITDA margin1of 24%.
READ MORE |
Verano Targets Industry’s Fastest-Growing Categories with Expansion of Savvy™ and (the) Essence™ Product Portfolios in Leading Cannabis Markets
Extra Savvy, Savvy Strut, Savvy 100 Proof and (the) Essence J’s feature large-format vapes with built-in digital engagement and barrel-style pre-rolls that deliver quality, convenience and affordability
CHICAGO, March 13, 2025 — Verano Holdings Corp. (Cboe CA: VRNO) (OTCQX: VRNOF) (“Verano” or the “Company”), a leading multi-state cannabis company, today announced the launch of a wave of new product innovation across the fastest-growing categories in key markets, including Extra Savvy 2-gram vape cartridges; Savvy Strut 2-gram all-in-one vapes; Savvy 100 Proof diamond-infused barrel-style pre-rolled joints; and (the) Essence J’s barrel-style pre-rolled joints.
Pre-rolled joints and vapes represent the fastest-growing categories in the industry, and the larger-format vape category specifically grew more than 400% in 20241. Demonstrating Verano’s focus on innovation, automation and differentiation, the Company is moving with speed and agility to meet consumer demand by leveraging in-house talent and cutting-edge manufacturing technology that exponentially increases production efficiency and output while preserving quality.
“As consumer appetite for differentiated cannabis products increases, particularly in the vape and pre-roll categories, we are excited to unleash a wave of innovation across our Savvy and (the) Essence portfolios featuring unique styles, experiences and engagement,” said David Spreckman, Verano Chief Marketing Officer. “Following the initial rollout of (the) Essence J’s and Extra Savvy 2-gram vape carts in some of the nation’s largest cannabis markets, Extra Savvy White Widow was the top-selling vape in Illinois last month1, and with Savvy 100 Proof pre-rolls and Savvy Strut 2-gram all-in-one vapes also launching in key states, we are well-positioned to further elevate our strong market positions in the fastest-growing categories.”
READ MORE |
Most large Public U.S. Cannabis companies (except Glass House) have now reported results for the 4th quarter of 2024.
In the Viridian Chart of the Week below, the top graph shows the actual y/o/y change in quarterly EBITDA for twelve companies. The green line shows the total percent change in EBITDA. Eight out of the twelve companies had declines in EBITDA for the quarter, ranging from 6.5% for Ascend (AAWH: OTCQX) to 42.9% for Cannabist (CBST: Cboe). The four gainers range from 7.7% for Green Thumb (GTII: CSE) to 26.6% for Trulieve (TRUL: CSE). The group, in aggregate, had a 5% y/o/y decline in EBITDA for the fourth quarter of 2024.
The blue bars show the part of the EBITDA % change that is attributable to changes in revenues, while the orange bars depict the EBITDA % change attributable to changes in margins. The impact of lower margins was the most significant factor in the EBITDA decline for eight of the twelve companies.
The bottom graph shows the same analysis but compares projected 2025 EBITDA to 2024 Actuals. Consensus estimates show EBITDA declines for seven companies in 2025 and an aggregate decline of 4.0% for the group, caused by an estimated sales decline of .7% and a 3.3% decline in EBITDA margins.
|
The cause for the declining margins is well known: continuing inflationary cost pressure paired with ongoing price compression. In addition, several managements have expressed overall macroeconomic concerns regarding overall weakening consumer demand. Unfortunately, excess capacity is difficult to squeeze out of the market due to high exit barriers. Moreover, once built, there is pressure to run facilities at full capacity as long as prices cover marginal costs, if not full costs.
Margin declines in 2025 may also relate to weakening pricing in Florida. Five of the seven companies with projected EBITDA declines have a significant presence in Florida.
The slightly negative growth projections for 2025 are due to the absence of new adult markets along with continuing price compression in maturing markets. Competition from intoxicating hemp is another restraining factor, albeit challenging to estimate. A more robust growth of 4.8% is projected for 2026, anticipating progress in Pennsylvania and/or Virginia. EBITDA margins for 2026 are projected to rebound to 2024 levels from the impact of the new markets.
Interestingly, the only companies that are projected to have significant EBITDA growth in 2025 are the Tier 2 and 3 MSOs: Ascend (AAWH: OTCQX), TerrAscend (TSND: TSX), Jushi (JUSHF: OTCQX), and MariMed (MRMD: CSE).
Investors should pay close attention to credit quality when they venture into smaller companies, which often have less financial flexibility. TerrAscend, Ascend, Jushi, and Marimed are ranked 11, 12, 16 & 17 on the Viridian Credit Tracker model, close to the middle of the 31 companies we credit rank each week.
View This Week's Viridian Chart of the Week For More Analysis About The Viridian Cannabis Deal Tracker
Launched in January 2015, and having analyzed more than $75B in deals, the Viridian Cannabis Deal Tracker is a proprietary data service that monitors and analyzes capital raise and M&A activity in the legal Cannabis, Hemp, and Psychedelics industries. Our insights help companies, investors, lenders and acquirers make informed capital allocation decisions. Each week the Deal Tracker provides proprietary data and market intelligence on transactions, including:
- Deals by Industry Sector (Track the Flow of Capital and M&A Deals by Industry Sector)
- Deal Structure (Equity/Debt for Capital Raises, Cash/Stock/Earnout for M&A)
- Principals to the Transaction (Issuer/Investor/Lender/Acquirer)
- Key Deal Terms (Deal Size, Valuation, Pricing, Warrants, Cost of Capital)
- Deals by Location of Issuer/Buyer/Seller (Track the Flow of Deals by State and Country)
- Credit Ratings (Leverage and Liquidity Ratios)
Contact
Scott Greiper
CEO
Viridian Capital Advisors, LLC
646.330.0704
sgreiper@viridianca.com
Broker-Dealer Services Provided Through Bradley Woods & Co. Ltd. - A Member of FINRA and SIPC,
845 Third Avenue, Suite 1703, New York, N.Y. 10022 |
NATIONAL AND INTERNATIONAL NEWS |
Springbig Announces Acquisition of VICE CRM and Appointment of Jaret Christopher as Chief Executive Officer
BOCA RATON, Fla., March 17, 2025 – SpringBig Holdings, Inc. (“Springbig” or the “Company”) (OTCQX: SBIG), a leading provider of SaaS-based marketing solutions, consumer mobile app experiences, and omnichannel loyalty programs, today announced the acquisition of VICE CRM, an AI-enabled performance marketing platform designed to optimize ROI for consumer marketing campaigns in highly regulated industries.
In addition, the Company has appointed VICE CRM founder, Jaret Christopher, as Chief Executive Officer effective April 1, 2025.
Jaret Christopher brings extensive leadership experience in SaaS-based businesses and knowledge of the cannabis market. Most recently, Jaret was General Manager and Vice President, CRM Software at WM Technologies, Inc., a position he held until last year following the sale of Sprout, a CRM and marketing software company he founded, to WM Technologies, Inc. in 2021. Prior to starting Sprout in 2017, Jaret was founder and CEO of multiple SaaS-based technology start-up businesses that he led to successful exits.
READ MORE |
Manitoba Harvest Collaborates with Whole Foods Market for Nationwide Launch of Superseed Snack Clusters
Tilray’s Leading Hemp Food Brand, Manitoba Harvest, Expands Superfood Portfolio with New Sweet and Salty Snacks
Manitoba Harvest Superseed Snack Clusters
NEW YORK, March 18, 2025 — Manitoba Harvest, the global leader in hemp foods and a Tilray Brands, Inc. company (“Tilray”) (NASDAQ: TLRY and TSX: TLRY), expands into functional snacking with new Superseed Snack Clusters, now exclusively available at select Whole Foods Market stores nationwide.
Innovation Backed by Nutrition
Crafted with premium seeds, including hemp hearts, pumpkin seeds, sunflower seeds, chia and flax, Manitoba Harvest’s Superseed Snack Clusters strike a perfect balance of crunchy and craveable. Enjoy convenient, guilt-free snacking with 5g of plant-based protein per serving, essential fatty acids, fiber, and key vitamins and minerals to help fuel your day.
“Our Superseed Snack Clusters are a delicious way to enjoy the benefits of hemp and other superseeds,” says Jared Simon, President of Manitoba Harvest and Tilray Wellness. “Snacking should be nourishing and satisfying, and these clusters deliver on both. We’re proud to collaborate with the visionary team at Whole Foods Market to bring these artisanal snacks to consumers nationwide.”
READ MORE | Tilray Brands Announces 420 Concert with Multi-Platinum Artist Don Toliver
Celebrate 420 with Tilray’s Leading Cannabis Brands and Nationwide Activations Across Canada
TORONTO, Feb. 26, 2025– Tilray Brands, Inc. company (Nasdaq: TLRY; TSX: TLRY), a global lifestyle and consumer packaged goods company at the forefront of beverage, cannabis and wellness industries, is set to elevate 420 celebrations across Canada with a series of dynamic consumer and industry events. This year’s 420 festivities will spotlight Tilray’s leading recreational cannabis brands—Good Supply, Redecan, Broken Coast, and XMG—through nationwide activations, pop-up events, and a marquee concert featuring multi-platinum artist Don Toliver on April 17, 2025, at Rebel, the iconic venue in Toronto, Ontario.
Set to be an unforgettable night, the Redecan 420 OG concert is designed to immerse attendees in a celebration of cannabis culture through music, interactive experiences, and exclusive perks. Don Toliver, renowned for his chart-topping tracks “No Idea,” “After Party,” “No Pole,” and “Bandit,” will headline the event, promising an electrifying performance that encapsulates the essence of 420. Celebrating alongside Redecan—a legacy Canadian cannabis brand that has grown from the ground up—420 OG emphasizes the community that has flourished over the years within cannabis culture, with a shared passion and deep-rooted respect for the plant.
READ MORE |
Cronos Group Reports 2024 Fourth Quarter and Full-Year Results
Net revenue in Q4 2024 increased by 27% year-over-year to $30.3 million; Net revenue in FY 2024 increased by 35% year-over-year to $117.6 million
Spinach® Ends 2024 as the Number One Cannabis Brand in Canada1
PEACE NATURALS® Ends 2024 as the Number One Cannabis Brand in Israel 2
Industry leading balance sheet with $859 million in cash and cash equivalents
TORONTO, Feb. 27, 2025 — Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”), today announced its 2024 fourth quarter and full-year business results.
“We set ambitious goals to deliver robust growth, improve margins, and achieve operational excellence. Today, I am proud to say that Cronos has not only met but exceeded these objectives, as evidenced by our strong 2024 results. Our unwavering commitment to innovation, quality, and disciplined cost management has solidified our leadership in the global cannabis industry,” said Mike Gorenstein, Chairman, President and CEO of Cronos.
“From Spinach® becoming the number one cannabis brand in Canada and PEACE NATURALS® achieving a number one position in Israel, to our groundbreaking advancements in cannabis genetics, to international expansion, Cronos is well-positioned to capitalize on future opportunities and drive long-term value for our shareholders. As we look ahead to 2025, we remain focused on sustaining this momentum, strengthening our market leadership, and delivering innovative products that resonate with consumers worldwide,” continued Mr. Gorenstein. “Our strategic investments, such as Cronos GrowCo, have enhanced our cultivation capabilities, ensuring a consistent supply of high-quality cannabis at scale with an improved gross margin profile, while our R&D breakthroughs have set new industry standards. Internationally, we’ve made significant strides, with PEACE NATURALS® leading in Israel and gaining traction in Germany and the UK. Combined with a robust balance sheet and a portfolio of best-selling, borderless brands, Cronos is not just leading today, we’re building the foundation for long-term excellence in the global cannabis industry. Looking to 2025, we’re excited about the opportunities ahead as we continue to innovate, expand, and deliver for our consumers and shareholders.”
READ MORE |
Blum Holdings Inc. Reports Remarkable 2024 Financial Results with $33.1 Million in Net Income
DOWNEY, Calif., March 13, 2025 — Blum Holdings, Inc. (OTCQB: BLMH) (the “Company,” “Blüm,” “Blüm Holdings,” “we” or “us”), a California-based publicly traded holding company and cannabis operator, announced its financial results for the year ended December 31, 2024, marking the completion of a significant financial and operational transformation.
Key Highlights from Fiscal Year 2024:
Net Income: $33.1 million, representing an astonishing turnaround from a net loss of $14.1 million in 2023 and a net loss of $188.7 million in 2022, reflecting the successful restructuring and cost optimization efforts.
Liability Reduction: Decreased by 62% to $29.6 million in 2024, from $77.8 million in 2023 and $125.3 million at the beginning of 2022, reflecting effective balance sheet management and successful restructuring strategies implemented during the tenure of the Adnant engagement.
Earnings per Share:
Basic: $1.79 in 2024, compared to a loss per share of $1.67 in 2023.
Diluted: $1.21 in 2024, compared to a loss per share of $1.67 in 2023.
Revenue Growth: Increased by 67% year-over-year to $13.0 million, an increase from $7.8 million in 2023, primarily driven by the successful integration of three Northern California retail stores, which contributed $7.7 million to revenue, partially offset by the strategic divestment of non-core dispensaries.
Gross Profit: Increased by 63% to $6.2 million, up from $3.8 million in 2023, with a gross margin of 48%, reflecting strong operational execution despite a competitive pricing environment.
EBITDA from Continuing Operations: $21.2 million, a $31.6 million improvement from an EBITDA loss of $10.4 million in 2023, highlighting enhanced operational efficiency and profitability.
Adjusted EBITDA from Continuing Operations: A loss of $10.9 million, a notable improvement from $16.8 million in 2023, underscoring management’s focus on financial performance.
Patty Chan, Chief Financial Officer of Blüm Holdings, commented: “Blüm’s 2024 performance is a testament to the disciplined execution of our financial, restructuring, litigation, and operational strategies. By strategically divesting underperforming assets, deconsolidating Unrivaled Brands and Halladay Holding, and integrating key retail locations, we have significantly streamlined our operations. These foundational improvements have strengthened our financial position, enabling us to enter 2025 as a more agile, efficient, and financially stable organization. With this momentum, we remain committed to disciplined capital allocation and strategic acquisitions that align with our long-term vision for sustainable growth and value creation.”
READ MORE |
Blum Holdings, Inc. Announces Final Global Settlement with People’s California, LLC
DOWNEY, Calif., Feb. 24, 2025 – Blum Holdings, Inc. (OTCQB: BLMH) (the “Company,” “Blüm,” “Blüm Holdings,” “we” or “us”), a California-based publicly traded holding company and cannabis operator, announced today that it has reached a global settlement with People’s California, LLC (“People’s California”) extinguishing over two and a half years of litigation brought by People’s California against Blüm Holdings and its wholly owned subsidiaries (and now debtors-in-possession in Chapter 11 bankruptcy proceedings), Unrivaled Brands, Inc. (“Unrivaled”) and Halladay Holding, LLC (“Halladay” and along with Unrivaled, the “Debtors”).
Pursuant to the binding terms spoken into the record for the United States Bankruptcy Judge mediating the matter, the settlement contemplated that “People’s will support the Debtor’s Chapter 11 plan…” and made explicit that “there’ll be a full and general release, a mutual release between the parties with 1542 waivers for the Debtors, the People’s parties, officers, directors, managers, agents, past and present, and attorneys, professionals, affiliates, subsidiaries, and parent companies on both sides.”
READ MORE |
Optimi Health Provides Corporate Update
VANCOUVER, BC – March 12, 2025 – Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), a GMP-compliant, Health Canada-licensed manufacturer specializing in botanical psilocybin and MDMA, is pleased to provide the following corporate update, highlighting key regulatory milestones, clinical trial progress, and expanded market access.
Expansion of MDMA Exports to the Australian Market
Optimi has received additional import permits for 1,000 doses of its GMP MDMA in 40mg and 60mg capsule formulations. This follows earlier shipments of 160 doses in August 2024, and 700 doses in October 2024, highlighting the expanding use of MDMA-assisted therapy and growing confidence in Optimi’s pharmaceutical-grade capsules throughout Australia.
Regulatory Progress: Australian BICON Permit Granted for Psilocybin Import
Optimi has obtained the necessary BICON import permit for its natural psilocybin extract capsules, enabling their legal entry into Australia. BICON (Biosecurity Import Conditions) is an Australian regulatory framework governing the importation of biological materials to ensure compliance with strict biosecurity and safety standards. Securing this permit is a key milestone, particularly for botanical-derived products like natural psilocybin, and reinforces Optimi’s ability to meet international pharmaceutical requirements.
READ MORE |
BELOW ARE THE LINKS TO THE DIRECTORY OF FLORIDA CANNABIS DOCTORS AND
DISPENSARIES IN THE STATE OF FLORIDA | QUALIFIED PATIENTS
OVER 903,000
AND 712 DISPENSING LOCATIONS |
LATEST OMMU REPORTS FROM OFFICE OF MEDICAL MARIJUANA USE IN THE STATE OF FLORIDA Highlights from
MARCH 14, 2025 Report BY THE NUMBERS
Qualified Patients: (Active ID Card)
MAR 14 2025- 903,790
MAR 07 2025- 902,566
FEB 28 2025- 902,647
FEB 21 2025- 901,726
FEB 14, 2025- 901,125
FEB 07, 2025- 900,625
Patients Last Week: 1,224
Qualified Ordering Physicians: 2,391
New Doctors Last Week: 0 Reporting Period: MAR 7 - MAR 13, 2025
Amount of Medical Marijuana Dispensed - (mgs THC) 385,365,755
Amount of Low-THC Cannabis Dispensed - (mgs CBD) 47,040
Amount of Marijuana in a From for Smoking (oz) 129,660.673
Approved Dispensing Locations: 713
Added Last Week: 3 PLANET 13 - ORNAGE PARK AND PORT RICHEY
TRULIEVE - MIAMI BEACH |
UPCOMING MEETING AND CONFERENCES |
In Case You Missed It:
Watch the MedCannCon24 Conference Recording! |
We are excited to announce that the recording of SCC's October 2024 Medical Cannabis Conference is now available for purchase.
This 2nd annual event brought together clinicians, researchers, experts, and advocates in the medical cannabis space to share groundbreaking insights, clinical applications, and the latest updates in cannabis science and policy. If you were unable to attend the conference or watch the livestream, this is your chance to access the wealth of information presented. All proceeds from this recording will support our mission to provide continuing education about the medical uses of cannabis and best practices in clinical care.
View the conference agenda HERE. Thank you for your continued support in helping us build a more informed and empowered community! Click the link below to purchase the recording. PURCHASE THE RECORDING |
ADVERTISEMENT OPPORTUNITIES
If your goal is to get your business in front of the right people in the cannabis industry or you want to be an integral part of this new and exciting business opportunity, then you need to join with Cannabis News Florida as we help to establish cannabis as a major part of the economy in Florida. Cannabis News Florida is an online publication focusing on both local and national news from leading authorities about the medical and business developments in the medical cannabis industry covering the entire state of Florida.
Join the Cannabis News Florida force online and in print. We offer several marketing options to fit all budgets:
· MMTC PROMOS LISTED IN EACH E-NEWSLETTER
• Directory Listing
• Banner Ads
• Ad Space in the Newspaper
• Feature Articles
• Weekly Newsletters
For further information or to make your ad reservation, please call:561-368-6950 / 954-605-4785 cell charles@cannabisnewsflorida.com
|
|
|